Submitting Your Abstract

Abstract submission is now closed.

New for IMMUNOLOGY2026™: abstracts are structured and submissions include 4 separate text boxes (introduction/rationale, methods, results and conclusion). More information below.

Renew or Join Now

Please Note: An AAI account is required to submit an abstract. AAI has launched a new and improved account platform. To register for an account, please visit members.aai.org. If you already have an AAI account but haven’t accessed the new system yet, go to members.aai.org to request a password reset. You can find more information and guidance in our User Guide. Once you’ve logged in, you can access the Abstract Submission Portal by clicking the “Submit an Abstract” button in your profile (see the screenshot for an example).

Key Abstract Dates:

Regular Abstract Dates
September 3 – October 22, 2025	First regular abstract submission period open
December 2 – December 16, 2025	Second regular abstract submission period open
December 5, 2025	First period invitations to present sent (estimate)
December 19, 2025	First period acceptance of invitation due (estimate)
Late-Breaking Abstract Dates
January 15 – 22, 2026	Late-Breaking Abstract submission period open
Date TBC	Invitation to present sent (estimate)
Date TBC	Acceptance of invitation due (estimate)

Submission Guidance

Abstract title should be no more than 200 characters (including spaces)
New for IMMUNOLOGY2026™: abstracts are structured and submissions include 4 separate text boxes (introduction/rationale, methods, results and conclusion) that make up the abstract rather than one paragraph as used in previous meetings. Maximum character count combined for all 4 text boxes is 2,000 characters, including spaces.
View the abstract topic categories to decide the best category that fits your abstract (NOTE: Abstract reviewers may determine your submission is better suited for a different topic category and move it accordingly).
Consider applying for a AAI Travel Award
The first author of the abstract must be the person linked to the membership number of the person submitting the abstract. Abstracts submitted by nonmembers using a current member’s membership number will be rejected.
Abstract submission fees are not refundable.
You are required to register for IMMUNOLOGY2026™ to present your abstract. This is a separate process from submitting an abstract. Registration opens December 17, 2025. You will be notified of your submission status prior to the close of the early-bird registration period (March 13, 2026).
Accepted abstracts will be presented as either a Major Symposium, Block or Poster presentation.

Abstract title (200 characters, including spaces)
Abstract description (2,000 characters total, including spaces) is structured as separate text boxes for the following categories: introduction/rationale, methods, results and conclusion.
First author information
Contributing authors Information
Funding sources
Conflict/s of Interest (COI)
Topic category
Keywords to help make your abstract searchable
Presentation preference (Major Symposium, podium or poster)

Create a clear and engaging title. The title should accurately reflect your presentation, be concise (ideally 12 words or less), and generate interest in your work.
Write concisely and avoid jargon. Use clear, straightforward language, avoiding overly complex sentences and unnecessary technical terms.
Be specific. Avoid vague statements and focus on providing precise information about your research and findings.
Highlight novelty and impact: Emphasize what makes your research unique and how it contributes to existing knowledge or practice.
Proofread. Ensure your abstract is error-free in terms of grammar, spelling, and punctuation.
Get feedback. Ask colleagues or mentors to review your abstract and provide constructive criticism.

Abstracts undergo a rigorous evaluation process to ensure the quality, relevance, and the originality of the presentations to be given at IMMUNOLOGY2026™. Approximately 18-20% of all submissions receive an invitation to present a podium presentation.

There is a preliminary check to ensure all abstracts meet the basic requirements, including appropriateness to the selected topic category. Qualified reviewers with expertise in the relevant fields/topic categories are selected and assigned to evaluate submitted abstracts based on these factors. Each abstract typically undergoes evaluation by two or three reviewers to ensure fairness and objectivity. Reviewers are recused from submissions if the reviewer is named as a first/co-author or has a familiarity with the first author.

Reviewers evaluate abstracts based on established criteria, including:

Originally and Innovation: Does the abstract present novel insights, approaches or findings that advance the field?
Clarity and Coherence: Is the abstract well organized, logically structured, and easy to understand?
Relevance to the Meeting: How well does the research align with the meeting’s focus areas/topic categories?
Methodological Soundness: Are the research methods appropriate, well-described, and likely to yield reliable and valid results?
Contribution to the Research Area: What is the potential impact of the research on the field?

Exceptional abstracts that are submitted during the regular submission period are assigned by reviewers to present in a podium presentation in Block Symposium. Trainees (as defined by AAI) can also be considered for a podium presentation in Major Symposium.

The IMMUNOLOGY2026™ Embargo and Copyright Policy can be found on our website..

Submission Fees

Members enjoy complimentary regular abstract submission. To submit an abstract for free, your membership must be renewed for 2026. Become an AAI member or renew your membership for 2026 to take advantage of the complimentary submission fee.

regular abstract

members

$0

Regular abstract submission open again December 2 – 16, 2025.

Submissions Closed

late-breaking abstract

members

$110

Late-breaking abstracts will be open January 15 – 22, 2026

Open January 15 – 22, 2026